Transcription initiation of genes associated with azole resistance in Candida albicans

References

• Odds F. Candida and Candidosis: a review and bibliography. 2nd edn. London: Bailliere Tindall, 1988.
   Google Scholar
• Law D, Moore CB, Wardle HM, Ganguli LA, Keaney MG, Denning DW. High prevalence of antifungal resistance in Candida spp. from patients with AIDS. J Antimicrob Chemother 1994; 34: 659–668.
   PubMed Web of Science ®Google Scholar
• Man KA, Seidel K, White TC, Bowden RA. Candidemia in allogeneic blood and marrow transplant recipients: evolution of risk factors after the adoption of prophylactic fluconazole. J Infect Dis 2000; 181: 309–316.
   PubMed Web of Science ®Google Scholar
• Mori T, Matsumura M, Kanamaru Y, et al. Myelofibrosis complicated by infection due to Candida albicans: emergence of resistance to antifungal agents during therapy. Clin Infect Dis 1997; 25: 1470–1471.
   Google Scholar
• Nolte FS, Parkinson T, Falconer DJ, et al. Isolation and characterization of fluconazole and amphotericin B-resistant Candida albicans from blood of two patients with leukemia. Antimicrob Agents Chemother 1997; 41: 196–199.
   PubMed Web of Science ®Google Scholar
• White TC, Marr KA, Bowden RA. Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. Clin Micro biol Rev 1998;382–402.
   Google Scholar
• Alarco, AM, Balan, I, Comte, F, et al. Molecular and phenotypic analyses of Candida albicans fluconazole-resistant clinical isolates. Abstract of ASM conference on Candida and Candi-diasis, Charleston, South Carolina, 1 March. American Society of Microbiology, 1999: C22.
   Google Scholar
• Calabrese, DC, Bille, J, and Sanglard, D. Analysis of resistance mechanisms to azole antifungal agents in sequential Candida albicans clinical isolates from AIDS patients. Abstract of ASM conference on Candida and Candidiasis, Charleston, South Carolina, 1 March. American Society of Microbiology, 1999: C55.
   Google Scholar
• Franz R, Kelly SL, Lamb DC, et al. Multiple molecular mechanisms contribute to a stepwise development of flucona-zole resistance in clinical Candida albicans strains. Antimicrob Agents Chemother 1998; 42: 3065–3072.
   PubMed Web of Science ®Google Scholar
• Krishnamurthy, S, Gupta, V, Panwar, S, and Prasad, R. Functional characterisation and expression studies of CDR1, a multidrug transporter from a pathogenic yeast Candida albicans, belonging to ABC transporter superfamily. Abstract of ASM conference on Candida and Candidiasis, Charleston, South Carolina, 1 March. American Society of Microbiology, 1999: C16.
   Google Scholar
• Lopez-Ribot JL, McAtee RK, Lee LN, et al. Distinct patterns of gene expression associated with development of fluconazole resistance in serial Candida albicans isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis. Antimicrob Agents Chemother 1998; 42: 2932–2937.
   Google Scholar
• Mueller FM, Kasai M, Francesconi A, Peter J, Walsh TJ. Expression of CDR1, MDR1 and ERG16 genes by RT-PCR from azole-resistant isolates of Candida albicans from pediatric HIV patients. Abstr Gen Meet Am Soc Microbiol 1998; 98: F49
   Google Scholar
• Sanglard D, Kuchler K, Ischer F, Pagani JL, Monod M, Bille J. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involved specific multidrug transporters. Antimicrob Agents Chemother 1995; 39:2378–2386.
   PubMed Web of Science ®Google Scholar
• White TC. Increased mRNA levels of ERG16, CDR, and MDR1 correlate with increases in azole resistance in Candida albicans isolates from a patient infected with human immundeficiency virus. Antimicrob Agents Chemother 1997; 41: 1482–1487.
   PubMed Web of Science ®Google Scholar
• Gupta V, Kohli A, Krishnamurthy S, et al. Identification of polymorphic mutant alleles of CaMDR1, a major facilitator of Candida albicans which confers multidrug resistance, and its in vitro transcriptional activation. Curr Genet 1998; 34: 192–199.
   Google Scholar
• Wirsching S, Michel S, Kohler G, Morschhauser J. Activation of the multiple drug resistance gene MDR1 in fluconazole-resistant, clinical Candida albicans strains is caused by mutations in a trans-regulatory factor. J Baaeriol 2000; 182: 400–404.
   PubMedGoogle Scholar
• Hitchcock CA. Resistance of Candida albicans to azole antifungal agents. Biochem Soc Trans 1993; 21: 1039–1047.
   PubMed Web of Science ®Google Scholar
• Clark FS, Parkinson T, Hitchcock CA, Gow NA. Correlation between rhodamine 123 accumulation and azole sensitivity in Candida species: possible role for drug efflux in drug resistance. Antimicrob Agents Chemother 1996; 40: 419–425.
   PubMed Web of Science ®Google Scholar
• Sanglard D, Ischer F, Monod M, Bille J. Susceptibilities of Candida albicans multidrug transporter mutants to various antifungal agents and other metabolic inhibitors. Antimicrob Agents Chemother 1996; 40: 2300–2305.
   PubMed Web of Science ®Google Scholar
• Sanglard D, Ischer F, Monod M, Bille J. Cloning of Candida albicans genes conferring resistance to azole antifungal agents: characterization of CDR2, a new multidrug ABC transporter gene. Microbiology 1997; 143:405–416.
   PubMed Web of Science ®Google Scholar
• White TC, Pfaller MA, Rinaldi MG, Smith J, Redding SW. Stable azole drug resistance associated with a substrain of Candida albicans from an HIV-infected patient. Oral D is 1997; 3 Suppl. 1: S102–109.
   Google Scholar
• Lamb DC, Kelly DE, White TC, Kelly SL. The R467K amino acid substitution in Candida albicans sterol 14 alpha-demethy-lase causes drug resistance through reduced affinity. Antimicrob Agents Chemother 2000; 44: 63–67.
   PubMed Web of Science ®Google Scholar
• De Micheli, M, Bille, J, and Sanglard, D. Regulation of ATP-binding cassette (ABC) transporter genes in Candida albicans. Abstract of ASM conference on Candida and Candidiasis, Charleston, South Carolina, 1 March 1999. American Society of Microbiology, 1999: C32.
   Google Scholar
• Puri N, Krishnamurthy S, Habib S, Hasnain SE, Goswami SK, Prasad K. CDR1, a multidrug resistance gene from Candida albicans, contains multiple regulatory domains in its promoter and the distal AP-1 element mediates its induction by miconazole. FEMS Microbiol Lett 1999; 180: 213–219.
   Google Scholar
• De Micheli, M, Bille, J, and Sanglard, D. Regulation of the major facilitator gene CaMD R1 in Candida albicans. Abstract of ASM conference on Candida and Candidiasis, Charleston, South Carolina, 1 March 1999. American Society of Microbiol-ogy, 1999: C53.
   Google Scholar
• Alarco AM, Raymond M. The bZip transcription factor Caplp is involved in multidrug resistance and oxidative stress response in Candida albicans. J Bacteriol 1999; 181: 700–708.
   PubMed Web of Science ®Google Scholar
• Henry KW, Nickels if, &Hind TD. Upregulation of ERG genes in Candida species by azoles and other sterol biosynthesis inhibitors. Antimicrob Agents Chemother 2000; 44: 2693–2700.
   Google Scholar